80 related articles for article (PubMed ID: 19539992)
1. Valproic acid exerts differential effects on CXCR4 expression in leukemic cells.
Gul H; Marquez-Curtis LA; Jahroudi N; Larratt LM; Janowska-Wieczorek A
Leuk Res; 2010 Feb; 34(2):235-42. PubMed ID: 19539992
[TBL] [Abstract][Full Text] [Related]
2. Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells.
Deubzer H; Busche B; Rönndahl G; Eikel D; Michaelis M; Cinatl J; Schulze S; Nau H; Witt O
Leuk Res; 2006 Sep; 30(9):1167-75. PubMed ID: 16510182
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling.
Gul H; Marquez-Curtis LA; Jahroudi N; Lo J; Turner AR; Janowska-Wieczorek A
Stem Cells Dev; 2009; 18(6):831-8. PubMed ID: 18847317
[TBL] [Abstract][Full Text] [Related]
4. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
[TBL] [Abstract][Full Text] [Related]
5. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
Mahmud N; Patel H; Hoffman R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
[TBL] [Abstract][Full Text] [Related]
6. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract][Full Text] [Related]
7. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia.
Bug G; Ritter M; Wassmann B; Schoch C; Heinzel T; Schwarz K; Romanski A; Kramer OH; Kampfmann M; Hoelzer D; Neubauer A; Ruthardt M; Ottmann OG
Cancer; 2005 Dec; 104(12):2717-25. PubMed ID: 16294345
[TBL] [Abstract][Full Text] [Related]
8. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.
Cheng YC; Lin H; Huang MJ; Chow JM; Lin S; Liu HE
Leuk Res; 2007 Oct; 31(10):1403-11. PubMed ID: 17445886
[TBL] [Abstract][Full Text] [Related]
10. Mucin1 expression is enriched in the human stem cell fraction of cord blood and is upregulated in majority of the AML cases.
Fatrai S; Schepers H; Tadema H; Vellenga E; Daenen SM; Schuringa JJ
Exp Hematol; 2008 Oct; 36(10):1254-65. PubMed ID: 18640764
[TBL] [Abstract][Full Text] [Related]
11. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles.
Ratajczak MZ; Majka M; Kucia M; Drukala J; Pietrzkowski Z; Peiper S; Janowska-Wieczorek A
Stem Cells; 2003; 21(3):363-71. PubMed ID: 12743331
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
14. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
[TBL] [Abstract][Full Text] [Related]
15. Molecular dissection of valproic acid effects in acute myeloid leukemia identifies predictive networks.
Rücker FG; Lang KM; Fütterer M; Komarica V; Schmid M; Döhner H; Schlenk RF; Döhner K; Knudsen S; Bullinger L
Epigenetics; 2016 Jul; 11(7):517-25. PubMed ID: 27309669
[TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
17. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells.
Kobune M; Kawano Y; Takahashi S; Takada K; Murase K; Iyama S; Sato T; Takimoto R; Niitsu Y; Kato J
Exp Hematol; 2008 Sep; 36(9):1121-31. PubMed ID: 18562079
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis.
Bogani C; Ponziani V; Guglielmelli P; Desterke C; Rosti V; Bosi A; Le Bousse-Kerdilès MC; Barosi G; Vannucchi AM;
Stem Cells; 2008 Aug; 26(8):1920-30. PubMed ID: 18511598
[TBL] [Abstract][Full Text] [Related]
19. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
20. Cytokine expansion culture of cord blood CD34+ cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions.
Denning-Kendall P; Singha S; Bradley B; Hows J
Stem Cells; 2003; 21(1):61-70. PubMed ID: 12529552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
